#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epileptic encephalopathy Cervix carcinoma recurrent Anti-myelin-associated glycoprotein antibodies positive Obesity Cutaneous lupus erythematosus Heart disease congenital Craniocerebral injury Hidradenitis Graft versus host disease Acute graft versus host disease in intestine Hydrocephalus Interstitial lung disease Neuropathic arthropathy Neuroendocrine tumour of the lung Breast angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Trials in Disease Antisynthetase syndrome – Trials in Disease Gaucher’s disease type I – Basic Information Acute respiratory distress syndrome – Trials in Disease Angelman’s syndrome – Diagnostics Sarcoma – Life with Disease Hereditary angioedema – Life with Disease Alveolar rhabdomyosarcoma – Life with Disease Idiopathic pulmonary fibrosis – Trials in Disease IgA nephropathy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    534 Keto-Isoleucine Calcium Hydralazine Hydrochloride Specific Nucleic Acid Sna-Her1 Cefoxitin Ferrous Sulfate Remibrutinib Ioflupane (123I) Linezolid Amphotericine B, Liposome Soya Oil, Purified Deferoxamine Mesilate Roxadustat Diltiazem Hydrochloride Pentixafor Gallium Ga-68 LTG-001 Indometacin Ph. Eur. Glycerol Phenylbutyrate Fosinopril Sodium Lurasidone More therapies…

    Learn about Your Condition

    Coronary artery disease Salivary gland cancer Gastrointestinal melanoma Pneumococcal infection Soft tissue sarcoma Choreoathetosis Leukaemia Cytokine release syndrome Malignant lymphoid neoplasm Iron deficiency anaemia Myxofibrosarcoma Neuromuscular scoliosis Takayasu's arteritis Nodal osteoarthritis Osteosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Redasemtide
    Belgium Czechia Denmark Finland France Germany +3

  • Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Gemcitabine
    The Netherlands Norway Spain Sweden

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Lenvatinib
    • Sorafenib
    Austria Belgium Bulgaria Croatia Estonia Finland +6

  • Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Baricitinib
    • Etanercept
    • Adalimumab
    Austria Belgium Czechia Denmark France Germany +9

  • Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    • Folinic Acid
    • Bevacizumab
    Portugal Spain

  • Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician’s Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer recurrent
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Paclitaxel
    • Sacituzumab Govitecan
    Czechia France Germany Greece Italy Poland +1

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Leuprorelin Acetate
    • Anastrozole
    • Camizestrant
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • A study testing tulisokibart for people with rheumatoid arthritis who have not responded well enough to previous treatments

    Not recruiting

    2 1
    Investigated Drugs:
    • Tulisokibart
    Germany Poland Spain

  • Study of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sar441566
    • Methotrexate
    Czechia Germany Greece Poland Slovakia Spain
Previous Page
1 … 11 12 13 14 15 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!